Evidence map›Paper›PMID 38169852›Full record

ArticleFrontiers in public health2023

Trends in outpatient and inpatient visits for separate ambulatory-care-sensitive conditions during the first year of the COVID-19 pandemic: a province-based study.

Tetyana Kendzerska, David T Zhu, Michael Pugliese, Douglas Manuel, Mohsen Sadatsafavi, Marcus Povitz, Therese A Stukel, Teresa To, Shawn D Aaron, Sunita Mulpuru and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Tetyana Kendzerska *The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
David T Zhu *The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Michael PuglieseThe Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Douglas ManuelThe Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Mohsen SadatsafaviRespiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
Marcus PovitzDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Therese A StukelICES, Ottawa, Toronto, ON, Canada.
Teresa ToICES, Ottawa, Toronto, ON, Canada.
Shawn D AaronThe Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Sunita MulpuruThe Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Melanie ChinThe Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Claire E KendallICES, Ottawa, Toronto, ON, Canada.
Kednapa ThavornThe Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Rebecca RobillardSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.
Andrea S GershonICES, Ottawa, Toronto, ON, Canada.
Ottawa Hospital Research InstituteOttawa Hospital · CAUniversity of Ottawa · CAHospital for Sick Children · CASunnybrook Research InstituteUniversity of British Columbia · CAUniversity of Miami · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic led to global disruptions in non-urgent health services, affecting health outcomes of individuals with ambulatory-care-sensitive conditions (ACSCs). Methods: We conducted a province-based study using Ontario health administrative data (Canada) to determine trends in outpatient visits and hospitalization rates (per 100,000 people) in the general adult population for seven ACSCs during the first pandemic year (March 2020-March 2021) compared to previous years (2016-2019), and how disruption in outpatient visits related to acute care use. ACSCs considered were chronic obstructive pulmonary disease (COPD), asthma, angina, congestive heart failure (CHF), hypertension, diabetes, and epilepsy. We used time series auto-regressive integrated moving-average models to compare observed versus projected rates. Results: Following an initial reduction (March-May 2020) in all types of visits, primary care outpatient visits (combined in-person and virtual) returned to pre-pandemic levels for asthma, angina, hypertension, and diabetes, remained below pre-pandemic levels for COPD, and rose above pre-pandemic levels for CHF (104.8 vs. 96.4, 95% CI: 89.4-104.0) and epilepsy (29.6 vs. 24.7, 95% CI: 22.1-27.5) by the end of the first pandemic year. Specialty visits returned to pre-pandemic levels for COPD, angina, CHF, hypertension, and diabetes, but remained above pre-pandemic levels for asthma (95.4 vs. 79.5, 95% CI: 70.7-89.5) and epilepsy (53.3 vs. 45.6, 95% CI: 41.2-50.5), by the end of the year. Virtual visit rates increased for all ACSCs. Among ACSCs, reductions in hospitalizations were most pronounced for COPD and asthma. CHF-related hospitalizations also decreased, albeit to a lesser extent. For angina, hypertension, diabetes, and epilepsy, hospitalization rates reduced initially, but returned to pre-pandemic levels by the end of the year. Conclusion: This study demonstrated variation in outpatient visit trends for different ACSCs in the first pandemic year. No outpatient visit trends resulted in increased hospitalizations for any ACSC; however, reductions in rates of asthma, COPD, and CHF hospitalizations persisted.

Indexed as

AsthmaCOVID-19Diabetes MellitusEpilepsyHypertensionPulmonary Disease, Chronic ObstructiveAdultAmbulatory CareHumansInpatientsOntarioOutpatientsPandemicsambulatory care sensitive conditionsARIMACOVID-19 pandemicinpatient visitsoutpatient visitstrends

Identifiers

PMID38169852
PMCPMC10759216
OpenAlexW4389885482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.